Real-time enrollment status for this colorectal cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:05 AM UTC
| NCT Number | NCT07023289 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Cancer |
| Phase | PHASE2 |
| Target Enrollment | 140 participants |
| Active Locations | 22 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT07023289 is currently recruiting participants. This phase2 study for colorectal cancer is actively seeking new participants at 22 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07023289 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07023289 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.